Quarter Financials
BiondVax Pharmaceuticals Ltd. (BVXV)
$1.36
+0.01 (+0.74%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Net Income | -4 | -4 | 6 | 10 | -12 | -8 | -11 | -9 |
|---|
| Dividend Paid | - | - | - | - | - | - | -24 | - |
|---|
| Retained Earnings | -123 | -119 | -116 | -383 | -387 | -374 | -365 | -354 |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Capital Expenditure | -0 | -0 | -0 | - | -0 | -1 | -0 | -0 |
|---|
| Net PPE | 12 | 12 | 13 | 44 | 44 | 45 | 44 | 44 |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| New Purchases | - | - | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|